Figure 3

Improvement in the 24 month vs baseline measurements of non-invasive liver fibrosis markers in each baseline fibrosis stage (mean, 95% CI).

Improvement in the 24 month vs baseline measurements of non-invasive liver fibrosis markers in each baseline fibrosis stage (mean, 95% CI).